Tuesday, May 30, 2017
Outbreak Victims' Survivors to Share $437,752
By Walter F. Roche Jr.
The two daughters of a Virginia victim of the 2012 fungal meningitis outbreak will share some $437,752 under a proposed settlement agreement filed in U.S. District Court in Boston, Mass.
According to the proposal before U.S. District Court Judge Rya W. Zobel, the settlement in the case totals some $979,345 with payments coming from the Virginia clinic where the victim was injected with fungus laden steroid and from the bankruptcy of the company that produced the tainted drugs, the New England Compounding Center.
The filing states that $836,432 will be paid by the Insight Health and other Virginia defendants, while $142,913 will be paid from a trust fund set up under the NECC bankruptcy.
From that total 40 per cent or $391,738 will go to the victim's law firm, Crandall and Katt, and $23,059 will cover costs associated with the litigation.
An additional $126,794 will go to repay the state Medicaid program and a health care provider for the victim.
The two daughters agreed to split the $437,752 remaining on a 50-50 basis. Any additional settlement payments will be split the same way, the agreement states.
Insight Health filed a motion in support of the agreement which is now subject to Zobel's approval.